DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Pridopidine is an investigational drug.
There have been 10 clinical trials for Pridopidine. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2008.
The most common disease conditions in clinical trials are Huntington Disease, Motor Neuron Disease, and Amyotrophic Lateral Sclerosis. The leading clinical trial sponsors are Prilenia, Teva Branded Pharmaceutical Products, R&D Inc., and Teva Branded Pharmaceutical Products R&D, Inc.
Recent Clinical Trials for Pridopidine
|HEALEY ALS Platform Trial - Regimen D Pridopidine||Prilenia Therapeutics||Phase 2/Phase 3|
|HEALEY ALS Platform Trial - Regimen D Pridopidine||Merit E. Cudkowicz, MD||Phase 2/Phase 3|
|PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD||Prilenia||Phase 3|